|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.82 CHF | -1.48% |
|
+5.31% | -2.49% |
| 04:08am | Holcim Reportedly Opposes Huaxin Cement's Bid for CSN Cement Unit | MT |
| 06-16 | Holcim Reportedly Opposes Huaxin Cement's Bid for CSN Cement Unit | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.22 | 3.71 | 4.85 | 5.02 | 3.16 | |||||
Return on Total Capital | 5.31 | 4.68 | 6.18 | 6.5 | 4.13 | |||||
Return On Equity % | 9.07 | 11.74 | 11.26 | 11.11 | 2.09 | |||||
Return on Common Equity | 8.48 | 11.68 | 11.13 | 10.98 | 1.83 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 42.66 | 41.78 | 42.57 | 43.98 | 42.34 | |||||
SG&A Margin | 28.44 | 29.83 | 26.72 | 27.72 | 28.22 | |||||
EBITDA Margin % | 20.58 | 18.12 | 21.84 | 22.43 | 19.91 | |||||
EBITA Margin % | 14.8 | 12.47 | 16.57 | 16.94 | 14.65 | |||||
EBIT Margin % | 14.22 | 11.94 | 15.85 | 16.27 | 14.12 | |||||
Income From Continuing Operations Margin % | 9.99 | 12.09 | 11.76 | 11.52 | 2.93 | |||||
Net Income Margin % | 8.56 | 11.33 | 11.33 | 11.08 | 83.81 | |||||
Net Avail. For Common Margin % | 8.5 | 11.27 | 11.27 | 11.07 | 2.47 | |||||
Normalized Net Income Margin | 7.22 | 6.44 | 9.14 | 9.26 | 8.46 | |||||
Levered Free Cash Flow Margin | 9.84 | 8.38 | 12.3 | 11.71 | 11.79 | |||||
Unlevered Free Cash Flow Margin | 10.78 | 9.35 | 13.58 | 12.99 | 13.08 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.47 | 0.5 | 0.49 | 0.49 | 0.36 | |||||
Fixed Assets Turnover | 1.1 | 1.3 | 1.36 | 1.33 | 0.96 | |||||
Receivables Turnover (Average Receivables) | 10.77 | 10.91 | 10.01 | 9.9 | 7.27 | |||||
Inventory Turnover (Average Inventory) | 6.7 | 6.22 | 5.47 | 4.99 | 3.75 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.41 | 1.89 | 1.44 | 1.25 | 1.32 | |||||
Quick Ratio | 1.06 | 1.49 | 1.06 | 0.88 | 1.04 | |||||
Operating Cash Flow to Current Liabilities | 0.52 | 0.52 | 0.61 | 0.58 | 0.38 | |||||
Days Sales Outstanding (Average Receivables) | 33.88 | 33.46 | 36.47 | 36.98 | 50.22 | |||||
Days Outstanding Inventory (Average Inventory) | 54.46 | 58.72 | 66.68 | 73.29 | 97.29 | |||||
Average Days Payable Outstanding | 77.7 | 81.88 | 95.13 | 102.3 | 180.17 | |||||
Cash Conversion Cycle (Average Days) | 10.64 | 10.29 | 8.01 | 7.97 | -32.66 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 55.48 | 54.47 | 52.57 | 49.57 | 57.49 | |||||
Total Debt / Total Capital | 35.68 | 35.26 | 34.46 | 33.14 | 36.5 | |||||
LT Debt/Equity | 47.63 | 48.88 | 47.29 | 42.98 | 48.91 | |||||
Long-Term Debt / Total Capital | 30.63 | 31.64 | 30.99 | 28.73 | 31.06 | |||||
Total Liabilities / Total Assets | 49.11 | 48.59 | 49.16 | 48.5 | 52.14 | |||||
EBIT / Interest Expense | 9.47 | 7.75 | 7.74 | 7.94 | 6.83 | |||||
EBITDA / Interest Expense | 14.62 | 12.55 | 11.32 | 11.67 | 10.27 | |||||
(EBITDA - Capex) / Interest Expense | 10.82 | 9.1 | 8.6 | 8.62 | 7 | |||||
Total Debt / EBITDA | 2.87 | 2.86 | 2.25 | 2.19 | 2.77 | |||||
Net Debt / EBITDA | 1.73 | 1.12 | 1.28 | 1.35 | 1.14 | |||||
Total Debt / (EBITDA - Capex) | 3.88 | 3.94 | 2.96 | 2.97 | 4.06 | |||||
Net Debt / (EBITDA - Capex) | 2.34 | 1.54 | 1.68 | 1.82 | 1.67 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 15.95 | 8.78 | -7.47 | -2.23 | -2.94 | |||||
Gross Profit, 1 Yr. Growth % | 18.15 | 6.52 | -5.71 | 1.24 | -5.77 | |||||
EBITDA, 1 Yr. Growth % | 14.19 | -4.24 | 10.53 | 1.11 | -2.85 | |||||
EBITA, 1 Yr. Growth % | 32.05 | -8.38 | 22.46 | 0.86 | -1.71 | |||||
EBIT, 1 Yr. Growth % | 32.04 | -8.65 | 22.27 | 1.3 | -2.93 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 33.92 | 31.59 | -10.01 | -4.22 | -70.74 | |||||
Net Income, 1 Yr. Growth % | 35.42 | 43.95 | -7.5 | -4.38 | 350.41 | |||||
Normalized Net Income, 1 Yr. Growth % | 39.15 | -2.09 | 31.23 | -0.94 | 6 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 35.77 | 46.77 | -2.01 | -2.43 | -72.97 | |||||
Accounts Receivable, 1 Yr. Growth % | 16.14 | -0.11 | 1.83 | -4.04 | -34.4 | |||||
Inventory, 1 Yr. Growth % | 31.52 | 9.66 | -1.85 | 11.04 | -44.95 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.91 | -16.71 | -4.99 | 4.99 | -38.3 | |||||
Total Assets, 1 Yr. Growth % | 12.52 | -3.81 | -8.54 | 3.03 | -38.1 | |||||
Tangible Book Value, 1 Yr. Growth % | -6.4 | 7.69 | -22.29 | -0.16 | -19.4 | |||||
Common Equity, 1 Yr. Growth % | 6.19 | 3.57 | -9.34 | 4.78 | -43.55 | |||||
Cash From Operations, 1 Yr. Growth % | 9.25 | -9.57 | 19.9 | 3.6 | -50.8 | |||||
Capital Expenditures, 1 Yr. Growth % | 37.52 | 1.11 | -2.84 | 9.63 | -2.21 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -36.79 | -7.34 | 33.33 | -6.18 | 16.32 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -35.1 | -5.69 | 32.27 | -5.8 | 11.04 | |||||
Dividend Per Share, 1 Yr. Growth % | 10 | 13.64 | 12 | 10.71 | -45.16 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 0.21 | 12.31 | 0.33 | -4.88 | -23.7 | |||||
Gross Profit, 2 Yr. CAGR % | 0.74 | 12.18 | 0.22 | -2.4 | -23.82 | |||||
EBITDA, 2 Yr. CAGR % | 1.78 | 4.57 | 3.37 | 5.35 | -26.9 | |||||
EBITA, 2 Yr. CAGR % | 8.18 | 9.99 | 6.16 | 10.63 | -27.94 | |||||
EBIT, 2 Yr. CAGR % | 8.61 | 9.83 | 5.93 | 10.76 | -27.63 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 3.29 | 32.75 | 8.82 | -7.16 | -61.94 | |||||
Net Income, 2 Yr. CAGR % | 1.15 | 39.62 | 15.39 | -5.95 | 107.53 | |||||
Normalized Net Income, 2 Yr. CAGR % | 8.64 | 16.23 | 13.35 | 14.02 | -26.61 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 0.54 | 41.16 | 19.92 | -2.22 | -63.83 | |||||
Accounts Receivable, 2 Yr. CAGR % | -3.44 | 7.71 | 0.86 | -1.15 | -20.66 | |||||
Inventory, 2 Yr. CAGR % | 2.26 | 20.09 | 3.74 | 4.4 | -21.81 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -5.19 | -8.32 | -11.04 | -0.12 | -19.51 | |||||
Total Assets, 2 Yr. CAGR % | 1.34 | 4.03 | -6.2 | -2.92 | -20.14 | |||||
Tangible Book Value, 2 Yr. CAGR % | -9.15 | 0.4 | -8.52 | -11.92 | -10.29 | |||||
Common Equity, 2 Yr. CAGR % | -1.55 | 4.87 | -3.1 | -2.53 | -23.09 | |||||
Cash From Operations, 2 Yr. CAGR % | 2.25 | -0.61 | 4.13 | 11.45 | -28.61 | |||||
Capital Expenditures, 2 Yr. CAGR % | -0.07 | 17.92 | -0.89 | 3.21 | -16.04 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -7.8 | -23.47 | 12.14 | 11.41 | -25 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -8.93 | -21.77 | 12.59 | 11.24 | -24.84 | |||||
Dividend Per Share, 2 Yr. CAGR % | 4.88 | 11.8 | 12.82 | 11.36 | -22.08 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0.77 | 2.99 | 5.29 | -0.53 | -18.63 | |||||
Gross Profit, 3 Yr. CAGR % | -0.29 | 2.63 | 5.87 | 0.48 | -18.27 | |||||
EBITDA, 3 Yr. CAGR % | 3.39 | -0.27 | 6.85 | 2.37 | -16.29 | |||||
EBITA, 3 Yr. CAGR % | 10.25 | 2.35 | 14.17 | 4.04 | -14.27 | |||||
EBIT, 3 Yr. CAGR % | 11.48 | 2.52 | 14 | 4.03 | -14.08 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 15.97 | 11.97 | 16.62 | 4.29 | -49.29 | |||||
Net Income, 3 Yr. CAGR % | 15.23 | 13.78 | 21.72 | 8.39 | 58.53 | |||||
Normalized Net Income, 3 Yr. CAGR % | 16.36 | 4.64 | 21.03 | 8.37 | -10.92 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 13.87 | 14.06 | 24.99 | 11.95 | -49.58 | |||||
Accounts Receivable, 3 Yr. CAGR % | -6.06 | -2.34 | 5.71 | -0.8 | -13.78 | |||||
Inventory, 3 Yr. CAGR % | -5.4 | 4.67 | 12.28 | 6.12 | -15.66 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -4.3 | -9.2 | -7.22 | -5.99 | -14.94 | |||||
Total Assets, 3 Yr. CAGR % | 0.11 | -0.41 | -0.34 | -3.22 | -16.44 | |||||
Tangible Book Value, 3 Yr. CAGR % | 0.59 | -3.85 | -7.82 | -5.81 | -14.48 | |||||
Common Equity, 3 Yr. CAGR % | 0.93 | 0.13 | -0.09 | -0.54 | -18.76 | |||||
Cash From Operations, 3 Yr. CAGR % | 19.08 | -1.85 | 5.81 | 3.95 | -15.14 | |||||
Capital Expenditures, 3 Yr. CAGR % | 2.78 | 0.32 | 10.55 | 2.5 | -11.85 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 24.74 | -7.65 | -7.37 | 5.4 | -9.38 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 16.81 | -7.86 | -6.3 | 5.84 | -9.47 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.23 | 7.72 | 11.87 | 12.11 | -12.06 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -0.05 | 1.56 | -0.34 | -0.24 | -7.44 | |||||
Gross Profit, 5 Yr. CAGR % | 0.31 | 8.91 | -0.09 | 0.59 | -7.23 | |||||
EBITDA, 5 Yr. CAGR % | 1.49 | 22.04 | 3.38 | 2.13 | -8.33 | |||||
EBITA, 5 Yr. CAGR % | 5.99 | 85.21 | 8.59 | 5.68 | -5.2 | |||||
EBIT, 5 Yr. CAGR % | 6.53 | 57.74 | 9.23 | 5.84 | -5.13 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 5.54 | 15.51 | 13.06 | 3.89 | -25.48 | |||||
Net Income, 5 Yr. CAGR % | 5.11 | 14.58 | 15.29 | 5.43 | 50.67 | |||||
Normalized Net Income, 5 Yr. CAGR % | 11.44 | 24.9 | 14.95 | 8.3 | -0.92 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 5.21 | 14.45 | 16.26 | 7.24 | -23.89 | |||||
Accounts Receivable, 5 Yr. CAGR % | -1.08 | -4.35 | -3.35 | -1.87 | -5.75 | |||||
Inventory, 5 Yr. CAGR % | -0.28 | -0.07 | -1.85 | 4.56 | -2.85 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -5.28 | -7.56 | -7.06 | -5.67 | -12.35 | |||||
Total Assets, 5 Yr. CAGR % | -2.97 | -1.99 | -2.47 | -1.42 | -8.79 | |||||
Tangible Book Value, 5 Yr. CAGR % | -1.95 | 1.65 | -3.16 | -7.16 | -8.82 | |||||
Common Equity, 5 Yr. CAGR % | -2.12 | 0.63 | -0.7 | -0.95 | -10.02 | |||||
Cash From Operations, 5 Yr. CAGR % | 8.89 | 8.46 | 12.86 | 3.27 | -9.6 | |||||
Capital Expenditures, 5 Yr. CAGR % | -2.88 | 0.35 | 1.3 | 1.47 | -0.97 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 25.77 | 12.17 | 19.54 | -0.1 | -15 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 16.96 | 8.2 | 15.1 | -0.33 | -14.33 | |||||
Dividend Per Share, 5 Yr. CAGR % | 1.92 | 4.56 | 6.96 | 9.16 | -3.2 |
- Stock Market
- Stocks
- HOLN Stock
- Financials Holcim Ltd
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















